Advertisement

Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse

  • Katherine Berry
  • Rory Allott
  • Richard Emsley
  • Sarah Ennion
  • Christine Barrowclough
Original Paper

Abstract

Purpose

The aims of the present study were to validate a measure of empowerment in a British population of people with a dual diagnosis of schizophrenia and substance misuse and assess relationships between empowerment and other key outcomes.

Method

Patients participating in a large randomised control trial for Motivational Interviewing for Drug and Alcohol misuse in Schizophrenia or psychosis (MIDAS trial) completed measures of empowerment, symptoms, global functioning and substance use at baseline, 12- and 24-month follow-ups.

Results

A three factor model of empowerment: self-efficacy and control; power and anger; and activism provided the best fit of the data across all three time points. There was some evidence of associations between empowerment and both symptoms and global functioning, although these associations were not consistent across subscales. Changes in empowerment predicted changes in symptoms and functioning at follow-up.

Conclusions

Empowerment is a broadly defined construct and its meaning may differ across different populations of people with severe and enduring mental health problems. Empowerment is a key component of recovery and should be assessed in treatments in addition to more traditional outcome measures of symptoms and functioning.

Keywords

Empowerment Schizophrenia Substance misuse 

Notes

Acknowledgments

We thank all participants who took part in the studies from the NHS Trusts and all the NHS staff who helped with recruitment. This research was supported by the Medical Research Council (MIDAS trial grant number—G0200471).

Conflict of interest

None.

References

  1. 1.
    Corrigan PW (2006) Impact of consumer-operated services on empowerment and recovery of people with psychiatric disabilities. Psychiatr Ser 57:1493–1496CrossRefGoogle Scholar
  2. 2.
    Warner R (2009) Recovery from schizophrenia and the recovery model. Curr Opin in Psychiatry 22:374–380CrossRefGoogle Scholar
  3. 3.
    Perkins R (2001) What constitutes success? The relative priority of service users’ and clinicians’ views of mental health services. Br J Psychiatry 179:9–10PubMedCrossRefGoogle Scholar
  4. 4.
    Ramon S, Healy B, Renouf N (2007) Recovery from mental illness as an emergent concept and practice in Australia and the UK. Int J Soc Psychiatry 53:108–122PubMedCrossRefGoogle Scholar
  5. 5.
    Rogers ES, Ralph RO, Saltzer MS (2010) Validating the empowerment scale with a multisite sample of consumers of mental health services. Psychiatr Ser 61:933–936CrossRefGoogle Scholar
  6. 6.
    Es Rogers, Chamberlin J, Ellison ML, Crean TA (1992) Consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Ser 48:1042–1047Google Scholar
  7. 7.
    Castelein S, Van Der Gaag M, Bruggeman R, Van Busschbacht JT, Weirsman D (2008) Measuring empowerment among people with psychotic disorders: a comparison of three instruments. Psychiatr Ser 59:1338–1344CrossRefGoogle Scholar
  8. 8.
    Corrigan PW, Faber D, Rashid F, Leary M (1999) The construct validity of empowerment among consumers of mental health services. Schizophr Res 38:77–84PubMedCrossRefGoogle Scholar
  9. 9.
    Maslin J (2003) Substance misuse in psychosis: contextual issues. In: Graham HL, Copella A, Birchwood MJ, Mueser KT (eds) Substance misuse in psychosis: approaches to treatment and service delivery. Wiley, UKGoogle Scholar
  10. 10.
    Weaver T, Rutter D, Maddon P, Ward J, Stimson G, Renton A (2001) Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 36:399–406PubMedCrossRefGoogle Scholar
  11. 11.
    Mccabe R, Saidi M, Priebe S (2007) Patients-reported outcomes in schizophrenia. Br J Psychiatry Suppl 50:21–28CrossRefGoogle Scholar
  12. 12.
    Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N (2010) Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and co-morbid substance misuse: randomised controlled trial. BMJ 341:c6325PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Kay SR, Flszbeln A, Qpjer LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRefGoogle Scholar
  14. 14.
    Kay SR, Opler LA, Lindenmayer JP (1988) Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99–110PubMedCrossRefGoogle Scholar
  15. 15.
    Hall RC (1995) Global assessment of functioning. A modified scale. Psychosomatics 36:267–270PubMedCrossRefGoogle Scholar
  16. 16.
    Jones SH, Thornicroft G, Coffey M, Dunn G (1995) A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF). B J Psychiatry 166:654–659CrossRefGoogle Scholar
  17. 17.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV), 4th edn. American Psychiatric Association, USAGoogle Scholar
  18. 18.
    Carey KB (1997) Reliability and validity of the time-line follow-back interview among psychiatric outpatients: a preliminary report. Addic Behav 11:26–33CrossRefGoogle Scholar
  19. 19.
    Carey KB, Carey MP, Maisto SA, Henson JM (2004) Temporal stability of the timeline follow-back interview for alcohol and drug use with psychiatric outpatients. J Stud Alcohol 65:774–781PubMedCentralPubMedGoogle Scholar
  20. 20.
    Stasiewicz P, Vincent PC, Bradizza CM, Conners GJ, Maisto SA, Mercer ND (2008) Factors affecting agreement between severely mentally ill alcohol abusers’ and collaterals’ reports of alcohol and other substance use. Psychol Addict Behav 22:78–87PubMedCrossRefGoogle Scholar
  21. 21.
    Lloyd C, King R, Moore L (2010) Subjective and objective indicators of recovery in severe mental illness: a cross-sectional study. Int J Soc Psychiatry 56:220–229PubMedCrossRefGoogle Scholar
  22. 22.
    Larsen T, Melle I, Auestad B, Friss S, Haar U, Johananessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2006) Substance abuse in first-episode non-affective psychosis. Schizophr Res 88:35–62CrossRefGoogle Scholar
  23. 23.
    Strack KM, Schulenburg E (2008) Understanding Empowerment, meaning, and perceived coercion in individuals with serious mental illness. J Clin Psychol 65:1137–1148CrossRefGoogle Scholar
  24. 24.
    Repper J, Perkins R (2003) Social inclusion and recovery. Bailliere Tindall, LondonGoogle Scholar
  25. 25.
    Miller WR, Rollinick S (2000) Motivational interviewing: preparing people for change, 2nd edn. Guilford Press, New YorkGoogle Scholar
  26. 26.
    Rogers ES, Teague G, Lichenstein C, Campbell J, Lyass A, Chen R, Banks S (2007) Effects of participation in consumer-operated service programs on both personal and organizationally mediated empowerment: results of multisite study. J Rehabil Res Dev 44:785–800PubMedCrossRefGoogle Scholar
  27. 27.
    Bejerholm U, Bjorkman T (2010) Empowerment in supported employment research and practice: is it relevant? Int J Soc Psychiatry 57:568–595Google Scholar
  28. 28.
    Vauth R, Klein B, Wirtz M, Corrigan PW (2007) Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Res 150:71–80PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Katherine Berry
    • 1
  • Rory Allott
    • 1
  • Richard Emsley
    • 1
  • Sarah Ennion
    • 1
  • Christine Barrowclough
    • 1
  1. 1.School of Psychological SciencesUniversity of ManchesterManchesterUK

Personalised recommendations